Welcome to Shandong Zhonglian Chemical Co., Ltd. Equity Code:880747
21
2025
-
11
A Pioneering Pharmaceutical Silica Excipient Revolutionizing Drug Delivery Systems
In the era of rapid advancement in medical technology, the demand for efficient drug delivery systems has become increasingly urgent.
In the era of rapid advancement in medical technology, the demand for efficient drug delivery systems has become increasingly urgent. Traditional drug carriers, limited by issues such as stability, targeting capability, and biocompatibility, have severely restricted the improvement of therapeutic effects. Meanwhile, nano-silica has emerged prominently in the field of drug carriers, becoming a highly focused research hotspot, thanks to its unique physicochemical properties and excellent biocompatibility. The advantages of nano-silica are multi-dimensional. It can effectively enhance drug stability, ensuring the long-lasting efficacy of medications. Additionally, it enables precise targeting of lesion sites, minimizing damage to normal tissues and thereby reducing drug side effects. Moreover, its good biocompatibility and degradability alleviate the metabolic burden on patients, providing dual guarantees for the safety and comfort of drug delivery. From the perspective of customer needs, nano-silica-based drug carriers also demonstrate strong adaptability. They can rapidly adsorb and load large quantities of drug molecules, significantly improving drug delivery efficiency. They allow precise control over the release rate and direction of drugs, achieving sustained and targeted drug delivery to ensure "accurate delivery and on-demand release". Furthermore, they reduce the number of excipients and formulation complexity, enhancing both drug efficacy and product stability. With excellent biocompatibility, they avoid toxic side effects on the human body, fundamentally ensuring medication safety. Among numerous nano-silica pharmaceutical products, ZLXIDE244FP pharmaceutical silica excipient stands out as a model. It is a high-purity, porous amorphous fumed silica excipient with exceptional moisture absorption capacity, which can effectively improve product stability and extend shelf life. Meanwhile, it exhibits significant chemical inertness, is colorless, odorless, and free of harmful components. It fully complies with the latest testing requirements of the 2020 Chinese Pharmacopoeia, EU No.231/2012 (E551), USP, and other standards, providing solid quality assurance for applications in the pharmaceutical field. In conclusion, nano-silica is driving the innovation of drug delivery systems with its outstanding performance and wide adaptability, injecting new vitality into the development of the pharmaceutical industry and bringing new hope for patients to obtain more efficient and safer treatment experiences.
Related Blog
Related Downloads
Service E-mail
Sales Add
Jinan City, Shandong Province,China
Production Add
Guangzhou City, Guangdong Province
